LoginSign Up
Scaled Biolabs

Scaled Biolabs

Scaled Biolabs has developed a platform based on microfluidic technology that allows researchers to perform thousands of simultaneous cell culture experiments.

Scaled Biolabs has developed a new platform based on microfluidic technology spun-out of The University of Queensland's Australian Institute for Bioengineering and Nanotechnology that allows researchers to perform thousands of simultaneous cell culture experiments.

Scaled Biolabs is developing a Cell Therapy Discovery Engine to create cell-based medicines. This engine allows biotech and pharma companies to survey hundreds of parameters across tens of thousands of experimental processes. Scaled Biolabs also develops cell therapy assets internally, including a CIRM-funded program focusing on iPSC-derived dopaminergic neurons as a curative cell therapy for Parkinson's disease.

Timeline

People

Name
Role
Related Golden topics

Brendan Griffen

Founder

Drew Titmarsh

Founder, CEO

Justin Cooper-White

Founder

Further reading

Title
Author
Link
Type

Celebrating Exciting CIRM-Funded Discovery Research on World Parkinson's Day

Karen Ring, CIRM

Web

Micro experiments have huge cellular impact

AIBN

Web

Platelet Biogenesis and Scaled Biolabs to Collaborate to Optimize Platelet Production Platform

BusinessWire

Web

Start-up makes quick work of cellular experiments

AIBN

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Scaled Biolabs Inc.

Drew Titmarsh, Ph.D.

San Francisco, CA

Cell Therapy Development Platform

References